41 Stocks Moving In Wednesday's Mid-Day Session

Gainers

  • Aurora Mobile Limited JG shares climbed 21.3% to $4.27 after Oppenheimer initiated coverage on the stock with an Outperform rating and a price target of $6 per share.
  • Creatd, Inc. CRTD gained 20.9% to $4.51 after the company reported strategic investment in Untamed Photographer, NFT Collaboration, and Vocal Community and Challenge Sponsorships.
  • RiceBran Technologies RIBT rose 18.2% to $1.3950 after jumping around 27% on Tuesday. The company is scheduled to report Q1 earnings today.
  • MicroVision, Inc. MVIS gained 17% to $23.68. MicroVision is scheduled to report Q1 earnings tomorrow. MicroVision reported completion of long-range lidar sensor A-Sample hardware and development platform.
  • Uxin Limited UXIN surged 15.3% to $2.3406 after the company reported Q3 earnings results.
  • Boxlight Corporation BOXL shares climbed 14.8% to $2.80. Maxim Group reiterated Boxlight with a Buy and announced a $6 price target.
  • Century Casinos, Inc. CNTY gained 14.8% to $12.88 after B. Riley FBR initiated coverage on the stock with a Buy rating and announced a price target of $18 per share.
  • ClearSign Technologies Corporation CLIR gained 14.4% to $4.9185 as the company received certification for firetube boiler burner in China.
  • Shopify Inc. SHOP surged 12% to $1,297.18 after the company reported better-than-expected Q1 results.
  • Unitil Corporation UTL gained 11.7% to $55.78. Unitil will replace Waddell & Reed Financial in the S&P SmallCap 600 prior to the opening of trading on Monday, May 3.
  • Deutsche Bank Aktiengesellschaft DB rose 10.1% to $13.60 after reporting upbeat quarterly profit.
  • Smart Share Global Limited EM gained 10.1% to $9.34.
  • GSX Techedu Inc. GSX rose 9.5% to $35.02. The company recently reported FY20 earnings results.
  • Calliditas Therapeutics AB CALT gained 9.5% to $31.48 after the company said the FDA has accepted the submission and granted priority review for the new drug application for Nefecon, a down regulator of IgA1 for the treatment of IgA nephropathy. The FDA has set a PDUFA goal date of Sept. 15.
  • Manhattan Associates, Inc. MANH surged 8.9% to $139.72 following upbeat quarterly results.
  • Haverty Furniture Companies, Inc. HVT rose 8.9% to $44.64 after the company reported better-than-expected Q1 results.
  • Genworth Financial, Inc. GNW gained 8.2% to $4.135. Genworth Financial will replace Glu Mobile in the S&P SmallCap 600 prior to the opening of trading on Monday, May 3.
  • NCR Corporation NCR surged 7.6% to $45.56 after the company reported better-than-expected Q1 results.
  • Genpact Limited G gained 6.3% to $47.85. Genpact will replace Genworth Financial in the S&P MidCap 400 prior to the opening of trading on Monday, May 3.
  • Mind Medicine (MindMed) Inc. MNMD rose 6.2% to $4.2682. Mind Medicine commenced trading its subordinate voting shares on The Nasdaq Capital Market Tuesday.
  • Alphabet Inc. GOOGL rose 5% to $2,406.00 after the company reported better-than-expected results for its first quarter and also announced a $50 billion Class C capital stock buyback program.


Check out these big penny stock gainers and losers

Losers

  • Protalix BioTherapeutics, Inc. PLX shares dipped 40% to $3.4973. Protalix BioTherapeutics and partner Chiesi announced that they received a complete response letter from the FDA regarding the biologics license application, seeking accelerated approval of pegunigalsidase alfa for the proposed treatment of adult patients with Fabry disease.
  • Urban Tea, Inc. MYT fell 37.9% to $2.88 after the company reported pricing of approximately $25million registered direct offering.
  • Benitec Biopharma Inc. BNTC dropped 24.1% to $4.1599 after the company reported that, due to demand, the underwriter has agreed to increase the size of the previously announced offering of 3.036 million shares of common stock at a price of $4.25 per share, for raising gross proceeds of $12.9 million.
  • BioVie Inc. BIVI fell 22% to $16.77 after the company announced it acquired biopharma assets from privately held NeurMedix.
  • R. R. Donnelley & Sons Company RRD dropped 18.3% to $4.83 after the company reported worse-than-expected Q1 earnings.
  • Revolution Medicines, Inc. RVMD fell 17.2% to $35.37.
  • Atea Pharmaceuticals, Inc. AVIR dipped 15.8% to $28.29.
  • Enphase Energy, Inc. ENPH fell 14.2% to $146.75 after the company issued weak Q2 sales guidance.
  • Nymox Pharmaceutical Corporation NYMX dropped 12.8% to $2.1450. Nymox Pharmaceutical’s director recently purchased 40,000 shares at an average price of $2.08 per share.
  • NetSol Technologies, Inc. NTWK dropped 12.6% to $4.7201 potentially on profit-taking after the stock rallied roughly 35% yesterday.
  • Pinterest, Inc. PINS fell 12.5% to $68.00 after the company reported Q1 earnings results.
  • Aldeyra Therapeutics, Inc. ALDX fell 12.1% to $13.06 after the company reported a proposed $125 million public offering of common stock.
  • Veoneer, Inc. VNE dipped 11.3% to $23.63 following downbeat quarterly sales.
  • Nxt-ID, Inc. NXTD fell 10.2% to $0.9255 after climbing around 15% on Tuesday.
  • F5 Networks, Inc. FFIV dropped 9.3% to $186.18 after the company reported Q2 results and issued Q3 forecast.
  • AzurRx BioPharma, Inc. AZRX fell 8.2% to $0.9451 after jumping over 15% on Tuesday.
  • Amgen Inc. AMGN fell 7.8% to $235.20 after the company reported worse-than-expected Q1 results.
  • Novavax, Inc. NVAX dipped 7.2% to $239.04.
  • Steven Madden, Ltd. SHOO fell 6.5% to $39.74 after the company issued Q2 guidance below analyst estimates.
  • Microsoft Corporation MSFT shares fell 3.1% to $253.79 after the company reported Q3 earnings results.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!